Mexico Respiratory Devices Market: Market Size & Forecast 2026

Mexico represents one of the larger medical device markets in Latin America, with its medtech base having grown from roughly $6 billion in 2017 to about $7 billion by 2022, a trajectory that continues to underpin demand for respiratory equipment. The respiratory devices segment is currently estimated at $8.5 billion in 2025 and is expanding at about 5.0% annually, outpacing the broader medical technology market. Demand spans therapeutic devices such as ventilators, CPAP and BiPAP machines, nebulizers, and oxygen concentrators, alongside diagnostic and monitoring tools including pulse oximeters, spirometers, and capnographs.

• •Estimated market size of $8.5 billion in 2025 with a 5.0% CAGR.
• •Anchored by Mexico's broader medtech market, which reached approximately $7 billion by 2022.
• •Encompasses both therapeutic devices (ventilators, CPAP/BiPAP, nebulizers, oxygen concentrators) and diagnostic monitors (pulse oximeters, spirometers).

The rising burden of chronic respiratory disease in Mexico, including COPD, asthma, and obstructive sleep apnea, is a primary driver of equipment demand as the population ages and urbanization increases exposure to risk factors. National statistics from agencies such as INEGI continue to document significant respiratory mortality and morbidity, reinforcing the case for expanded therapeutic capacity in both inpatient and home-care settings. Greater private-sector investment in hospital infrastructure, broader penetration of health insurance, and the post-pandemic normalization of home-based respiratory care are accelerating device adoption.

• •Growing prevalence of COPD, asthma, sleep apnea, and post-viral respiratory complications.
• •Expanding private hospital network and wider health insurance coverage driving equipment procurement.
• •Permanent shift toward home-based respiratory therapy and remote monitoring following COVID-19.

By product type, the market splits into therapeutic devices, which dominate spending, and diagnostic and monitoring devices, which are growing fastest due to digital and wearable innovation. By end user, hospitals and intensive care units remain the largest purchasers, while home-care settings are the fastest-growing segment as insurers and patients favor outpatient management of chronic conditions. Geographically, demand is concentrated in metropolitan areas such as Mexico City, Guadalajara, and Monterrey, while manufacturing and assembly activity is clustered in Querétaro, Baja California, and Jalisco.

• •Therapeutic devices lead revenue; diagnostic and wearable monitors are the fastest-growing sub-segment.
• •Home-care is the highest-growth end-user category, though hospitals still account for the largest share.
• •Manufacturing footprint concentrated in Querétaro, Baja California, and Jalisco; consumption strongest in Mexico City, Guadalajara, and Monterrey.

What are the recent trends and outlook?

The most significant trend shaping the market is the digitalization of respiratory care, with smart inhalers, cloud-connected CPAP devices, and wearable SpO2 sensors becoming standard features rather than premium options. Climate-related factors highlighted by international health forums are also drawing attention to resilient respiratory infrastructure, including portable ventilators and oxygen systems suited to disaster-prone regions. Through 2030, sustained 5.0% annual growth is expected as device miniaturization, telemedicine integration, and continued nearshoring of medical device manufacturing reinforce Mexico's position in the North American respiratory care supply chain.

• •Smart, connected inhalers and CPAP devices are moving from premium to mainstream product tiers.
• •Climate resilience is driving demand for portable ventilators and oxygen systems in disaster-prone areas.
• •Continued nearshoring is expected to strengthen Mexico's role within the North American respiratory device supply chain through 2030.